HIGH-DOSE METHOTREXATE USED ALONE AND IN COMBINATION FOR MEASURABLE PRIMARY OR METASTATIC OSTEO-SARCOMA
- 1 January 1980
- journal article
- research article
- Vol. 64 (1) , 11-20
Abstract
High-dose methotrexate with leucovorin rescue was used alone or in combination with adriamycin and cyclophosphamide for the treatment of 27 osteosarcoma patients with measurable indicators of disease. Three patients developed complete responses of measurable lesion, 2 had partial responses, 2 had static disease, 1 had symptomatic improvement, and 1 had return to normal of physical findings following treatment of a flat bone primary osteosarcoma. While the doses and frequency of administration of high-dose methotrexate differed from those used by previous investigators, aggressive treatment with high-dose methotrexate must be attempted to further evaluate its efficacy as single-agent therapy for osteosarcoma patients not eligible for adjuvant chemotherapy trials.This publication has 6 references indexed in Scilit:
- Chemotherapy and thoractomy for metastatic osteogenic sarcoma.A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgeryCancer, 1978
- AGE-RELATED ADRIAMYCIN CARDIOTOXICITY IN CHILDREN1978
- A New Familial Cancer Syndrome? A Spectrum of Malignant and Benign Tumors Including Retinoblastoma, Carcinoma of the Bladder and Other Genitourinary Tumors, Thyroid Adenoma, and a Probable Case of Multifocal Osteosarcoma2JNCI Journal of the National Cancer Institute, 1977
- RECOVERY FROM TOXICITY ASSOCIATED WITH HIGH-DOSE METHOTREXATE - PROGNOSTIC FACTORS1977
- Adjuvant multiple drug chemotherapy for osteosarcoma of the extremityCancer, 1977
- Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma.Pre-surgical treatment of primary tumor and of overt pulmonary metastasesCancer, 1977